![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Antiretroviral Drugs Associated with Subclinical Coronary Artery Disease.
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Helen Kovari1, Alexandra Calmy2, ThanhDoco-Lecompte2, René Nkoulou3, Alex Marzel1,Rainer Weber1, Philipp A. Kaufmann4, Ronny R. Buechel4, Bruno Ledergerber1*, Philip E. Tarr5* , and the Swiss HIV Cohort Study1Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland;2Division of Infectious Diseases, University Hospital Geneva, University of Geneva; 3Division of Cardiology, University Hospital Geneva; 4Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich ; 5Department of Medicine and Division of Infectious Diseases and Hospital Epidemiology, KantonsspitalBaselland, University of Basel, Switzerland.*Both authors contributed equally.
![0321181](../images%20/032118/032118-2/0321181.gif)
![0321182](../images%20/032118/032118-2/0321182.gif)
![0321183](../images%20/032118/032118-2/0321183.gif)
![0321184](../images%20/032118/032118-2/0321184.gif)
![0321185](../images%20/032118/032118-2/0321185.gif)
![0321186](../images%20/032118/032118-2/0321186.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|